000 01513 a2200421 4500
005 20250513175954.0
264 0 _c19990607
008 199906s 0 0 eng d
022 _a0003-4932
024 7 _a10.1097/00000658-199905000-00016
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRose, D M
245 0 0 _a18Fluorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer.
_h[electronic resource]
260 _bAnnals of surgery
_cMay 1999
300 _a729-37; discussion 737-8 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S.; Review
650 0 4 _aAdenocarcinoma
_xdiagnostic imaging
650 0 4 _aFluorodeoxyglucose F18
650 0 4 _aHumans
650 0 4 _aPancreatic Neoplasms
_xdiagnostic imaging
650 0 4 _aPredictive Value of Tests
650 0 4 _aRadiopharmaceuticals
650 0 4 _aReproducibility of Results
650 0 4 _aSensitivity and Specificity
650 0 4 _aTomography, Emission-Computed
700 1 _aDelbeke, D
700 1 _aBeauchamp, R D
700 1 _aChapman, W C
700 1 _aSandler, M P
700 1 _aSharp, K W
700 1 _aRichards, W O
700 1 _aWright, J K
700 1 _aFrexes, M E
700 1 _aPinson, C W
700 1 _aLeach, S D
773 0 _tAnnals of surgery
_gvol. 229
_gno. 5
_gp. 729-37; discussion 737-8
856 4 0 _uhttps://doi.org/10.1097/00000658-199905000-00016
_zAvailable from publisher's website
999 _c10194469
_d10194469